Cancer outcomes are independent of preoperative CA 19-9 in anatomically resectable pancreatic ductal adenocarcinoma: A retrospective cohort analysis.

Joon Kyung KimDanielle K DePeraltaTakuya OgamiJason W DenboJose PimientoPamela J HodulMokenge P MalafaDae W KimJason B FlemingBenjamin D Powers

Published in: Journal of surgical oncology (2020)

Although guidelines recommend CA 19-9 to determine the management of anatomically resectable PDAC patients, CA 19-9 was not associated with recurrence or OS in this cohort. Our findings do not suggest that CA 19-9 alone should determine the PDAC treatment strategy.

Keyphrases

end stage renal disease
protein kinase
ejection fraction
newly diagnosed
papillary thyroid
prognostic factors
locally advanced
peritoneal dialysis
metabolic syndrome
radiation therapy
combination therapy
replacement therapy
childhood cancer